Douglas P. Ahrens

Tunable cytotoxic aptamer–drug conjugates for the treatment of prostate cancer

Bethany Powell Gray, Linsley Kelly, Douglas P. Ahrens et al. · Proceedings of the National Academy of Sciences · 2018 · 143 citations · Full text

Drug Targeting, Polymer-drug Conjugate, Medicine +11

Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth

Jonathan W. Kotula, Jin‐Peng Sun, Margie Li et al. · PLoS ONE · 2014 · 49 citations · Full text

Conservation of the WD-repeat, microtubule-binding protein, EMAP, in sea urchins, humans, and the nematode C. elegans

Kathy A. Suprenant, J. A. Tuxhorn, Melissa A. F. Daggett et al. · Development Genes and Evolution · 2000 · 29 citations

Biology, Signal Transduction, Molecular Physiology +11

Saturable binding of the echinoderm microtubule‐associated protein (EMAP) on microtubules, but not filamentous actin or vimentin filaments

Bernd Eichenmüller, Douglas P. Ahrens, Qingwen Li et al. · Cell Motility and the Cytoskeleton · 2001 · 14 citations

Immunocytochemical Technique, Molecular Biology, Cytoskeleton +20